Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRDF Cardiff Oncology, Inc.

盘后交易 11-25 18:37:45 EST

2.45

+0.00

0.00%

盘后2.50

+0.05+2.04%

16:53 EST

最高2.63	最低2.44	成交量61.68万
今开2.49	昨收2.45	日振幅7.76%
总市值1.25亿	流通市值1.17亿	总股本5,113万
成交额154.24万	换手率1.29%	流通股本4,776万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRDF","market":"US","secType":"STK","nameCN":"Cardiff Oncology, Inc.","latestPrice":2.45,"timestamp":1732568400000,"preClose":2.45,"halted":0,"volume":616780,"hourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.45,"latestTime":"16:53 EST","volume":7525,"amount":18545.050212500002,"timestamp":1732571607984},"delay":0,"floatShares":47757600,"shares":51133747,"eps":-0.950476,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"11-25 18:37:45 EST","open":2.49,"high":2.63,"low":2.44,"amount":1542419.122868,"amplitude":0.077551,"askPrice":2.54,"askSize":200,"bidPrice":2.44,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.950476,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732582800000},"adr":0,"listingDate":1059624000000,"adjPreClose":2.45,"preHourTrading":{"tag":"盘前","latestPrice":2.5,"preClose":2.45,"latestTime":"09:29 EST","volume":560,"amount":1385.2628160000002,"timestamp":1732544999903},"postHourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.45,"latestTime":"16:53 EST","volume":7525,"amount":18545.050212500002,"timestamp":1732571607984},"volumeRatio":1.199391,"impliedVol":2.9051,"impliedVolPercentile":0.9524},"requestUrl":"/m/hq/s/CRDF","defaultTab":"news","newsList":[{"id":"2486036080","title":"Cardiff Oncology, Inc.盘中异动 早盘大幅上涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486036080?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:37","pubTimestamp":1732545467,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时37分，Cardiff Oncology, Inc.股票出现异动，股价急速上涨5.71%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为90.25%、66.76%、41.55%，振幅较大的相关个股有Kodiak Sciences Inc、Werewolf Therapeutics, Inc.、Anixa Biosciences, Inc.，振幅分别为106.46%、105.79%、105.63%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522374798e44690&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522374798e44690&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2483147370","title":"Cardiff Oncology, Inc.盘中异动 急速下挫5.81%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483147370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483147370?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:00","pubTimestamp":1731682808,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时00分，Cardiff Oncology, Inc.股票出现波动，股价大幅下跌5.81%。截至发稿，该股报2.68美元/股，成交量21.244万股，换手率0.42%，振幅6.34%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为2.37%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523000898e42f6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523000898e42f6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2483331656","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483331656?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:10","pubTimestamp":1731615001,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时10分，Cardiff Oncology, Inc.股票出现波动，股价大幅下跌5.22%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504100198e42b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504100198e42b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2483395758","title":"Cardiff Oncology, Inc.盘中异动 临近午盘快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483395758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483395758?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:40","pubTimestamp":1731516052,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时40分，Cardiff Oncology, Inc.股票出现异动，股价急速跳水5.06%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114004053a2349f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114004053a2349f88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2482823735","title":"Cardiff Oncology, Inc.盘中异动 急速拉升5.36%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482823735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482823735?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:50","pubTimestamp":1731336608,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时50分，Cardiff Oncology, Inc.股票出现异动，股价快速拉升5.36%。截至发稿，该股报3.25美元/股，成交量21.1802万股，换手率0.46%，振幅3.90%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225008971a5b93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225008971a5b93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2481101915","title":"Cardiff Oncology, Inc.盘中异动 大幅下跌6.00%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101915?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076271,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分，Cardiff Oncology, Inc.股票出现波动，股价急速下挫6.00%。截至发稿，该股报3.84美元/股，成交量6.4633万股，换手率0.14%，振幅2.44%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223116971a55b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223116971a55b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2481183841","title":"卡迪夫肿瘤公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481183841","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481183841?lang=zh_cn&edition=full","pubTime":"2024-11-08 13:05","pubTimestamp":1731042348,"startTime":"0","endTime":"0","summary":"卡迪夫肿瘤公司公布截至 9 月 30 日的季度业绩 - 收益摘要卡迪夫肿瘤公司CRDF.OQ公布了截至9月30日的季度调整后每股亏损25美分，低于去年同期的每股收益-22美分。五位分析师对该季度的平均预期是每股亏损 27 美分。该公司本季度亏损 1,186 万美元。卡迪夫肿瘤公司股价本季度上涨了 42.7%，今年迄今为止上涨了 157.4%。华尔街对 Cardiff Oncology Inc 的 12 个月目标价中位数为 8.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF0KI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2481935243","title":"Cardiff Oncology, Inc.盘中异动 大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481935243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481935243?lang=zh_cn&edition=full","pubTime":"2024-11-07 01:25","pubTimestamp":1730913900,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日01时25分，Cardiff Oncology, Inc.股票出现波动，股价急速拉升5.15%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110701250098e40f4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110701250098e40f4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2481624688","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.08%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624688?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:36","pubTimestamp":1730817417,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时36分，Cardiff Oncology, Inc.股票出现异动，股价大幅跳水5.08%。截至发稿，该股报3.55美元/股，成交量3.1212万股，换手率0.07%，振幅3.21%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223658aba23e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223658aba23e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2480158428","title":"Cardiff Oncology, Inc.盘中异动 快速上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480158428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480158428?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:01","pubTimestamp":1730732493,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时01分，Cardiff Oncology, Inc.股票出现波动，股价大幅上涨5.42%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、In8Bio, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为257.74%、217.91%、56.79%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、In8Bio, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为31.90%、31.42%、29.83%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230133971a42ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230133971a42ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2480881405","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.13%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881405?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:54","pubTimestamp":1730469257,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时54分，Cardiff Oncology, Inc.股票出现波动，股价急速拉升5.13%。截至发稿，该股报3.28美元/股，成交量8.1775万股，换手率0.18%，振幅5.13%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215417971a3dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215417971a3dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2479566162","title":"Cardiff Oncology, Inc.盘中异动 快速拉升5.35%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479566162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479566162?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:26","pubTimestamp":1730229987,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时26分，Cardiff Oncology, Inc.股票出现异动，股价大幅拉升5.35%。截至发稿，该股报3.15美元/股，成交量76.6026万股，换手率1.65%，振幅6.35%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030032627ab7fcf19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030032627ab7fcf19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2479408378","title":"卡迪夫肿瘤公司  预计每股亏损27美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479408378","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479408378?lang=zh_cn&edition=full","pubTime":"2024-10-29 19:22","pubTimestamp":1730200964,"startTime":"0","endTime":"0","summary":"   * 卡迪夫肿瘤公司   预计将在10月31日公布截至2024年9月30日的业绩报告(预计)，季度收入将出现下降。* LSEG 分析师对 Cardiff Oncology Inc 的平均预期是每股亏损 27 美分。* 华尔街对 Cardiff Oncology Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 2.99 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"卡迪夫肿瘤公司  预计每股亏损27美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDF"],"gpt_icon":0},{"id":"2478481319","title":"Cardiff Oncology, Inc.盘中异动 早盘急速上涨5.30%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481319?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:40","pubTimestamp":1730122806,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时40分，Cardiff Oncology, Inc.股票出现波动，股价急速上涨5.30%。截至发稿，该股报2.98美元/股，成交量5.1226万股，换手率0.11%，振幅3.53%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214006a1f25178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214006a1f25178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2478493111","title":"Cardiff Oncology, Inc.盘中异动 早盘急速拉升5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478493111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478493111?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:29","pubTimestamp":1729866548,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时29分，Cardiff Oncology, Inc.股票出现波动，股价大幅拉升5.49%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522290898e3e86f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522290898e3e86f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":1},{"id":"2477863700","title":"Cardiff Oncology, Inc.盘中异动 早盘急速跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477863700?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:34","pubTimestamp":1729517689,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时34分，Cardiff Oncology, Inc.股票出现异动，股价急速跳水5.17%。截至发稿，该股报2.75美元/股，成交量9.8568万股，换手率0.21%，振幅4.14%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213449ab6bb787&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213449ab6bb787&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2476259949","title":"Cardiff Oncology, Inc.盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476259949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476259949?lang=zh_cn&edition=full","pubTime":"2024-10-18 22:11","pubTimestamp":1729260669,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日22时11分，Cardiff Oncology, Inc.股票出现波动，股价急速上涨5.02%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018221109971a1231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018221109971a1231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2475163209","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.06%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475163209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475163209?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:15","pubTimestamp":1729088113,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时15分，Cardiff Oncology, Inc.股票出现异动，股价大幅拉升5.06%。截至发稿，该股报2.81美元/股，成交量9.3977万股，换手率0.20%，振幅4.12%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622151398e3cca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622151398e3cca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2474027902","title":"Cardiff Oncology, Inc.盘中异动 快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474027902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474027902?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:41","pubTimestamp":1728492079,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日00时41分，Cardiff Oncology, Inc.股票出现波动，股价快速下跌5.11%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101000412098e3b82d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101000412098e3b82d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2473973488","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.77%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473973488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473973488?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:54","pubTimestamp":1728316483,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时54分，Cardiff Oncology, Inc.股票出现波动，股价急速上涨5.77%。截至发稿，该股报2.75美元/股，成交量33.363万股，换手率0.72%，振幅5.38%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072354439719eaf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072354439719eaf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiffoncology.com","stockEarnings":[{"period":"1week","weight":-0.0504},{"period":"1month","weight":-0.1434},{"period":"3month","weight":0.0251},{"period":"6month","weight":-0.2878},{"period":"1year","weight":1.0588},{"period":"ytd","weight":0.6554}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cardiff Oncology, Inc.是一家出于发展阶段的分子诊断公司，专注由专有产权的诊断技术的开发和市场推广，这种技术在各种医学诊所用于患者/疾病的扫描和监视。公司主要的内部焦点是操作新型的尿液分子诊断平台，以促进在治疗肿瘤领域的进步，外部焦点包括了在传染病、移植医疗和产前诊断领域发展合作。公司于2002年4月26日以Used Kar Parts公司之名成立于弗罗里达。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.0094},{"month":2,"riseRate":0.416667,"avgChangeRate":0.317908},{"month":3,"riseRate":0.416667,"avgChangeRate":0.122926},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.067525},{"month":5,"riseRate":0.416667,"avgChangeRate":0.036218},{"month":6,"riseRate":0.416667,"avgChangeRate":0.317983},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.066363},{"month":8,"riseRate":0.615385,"avgChangeRate":0.117352},{"month":9,"riseRate":0.307692,"avgChangeRate":0.018925},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.026835},{"month":11,"riseRate":0.384615,"avgChangeRate":0.033296},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.087919}],"exchange":"NASDAQ","name":"Cardiff Oncology, Inc.","nameEN":"Cardiff Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cardiff Oncology, Inc.,CRDF,Cardiff Oncology, Inc.股票,Cardiff Oncology, Inc.股票老虎,Cardiff Oncology, Inc.股票老虎国际,Cardiff Oncology, Inc.行情,Cardiff Oncology, Inc.股票行情,Cardiff Oncology, Inc.股价,Cardiff Oncology, Inc.股市,Cardiff Oncology, Inc.股票价格,Cardiff Oncology, Inc.股票交易,Cardiff Oncology, Inc.股票购买,Cardiff Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}